PharVision Advisers’s Rio Tinto RIO Stock Holding History

PharVision Advisers’s Portfolio RIO Stock Details RIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,844	Closed	-$228K	–	530
2025 Q4	$228K	Buy	+2,844	New	+$205K	0.12%	454

Other funds holding RIO

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's RIO Position: Q1 2026 in Review

PharVision Advisers sold out of Rio Tinto (RIO) in Q1 2026, closing a stake of 2,844 shares — an estimated $228K sold.

PharVision Advisers first reported a position in RIO in Q4 2025 and held it in 1 quarter. The position peaked at $228K in Q4 2025. 933 funds tracked by Wall St. Rank hold RIO as of Q1 2026.

PharVision Advisers reported no remaining Rio Tinto position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,844 Rio Tinto shares in Q1 2026, an estimated $228K.
PharVision Advisers first reported a position in Rio Tinto in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Rio Tinto position peaked at $228K in Q4 2025.
933 funds tracked by Wall St. Rank held Rio Tinto as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.